decisionhealth Newsletters, Part B News - 2017 Issue 1 (January)
Trump health care order a ‘signal’; Price vague on ACA replacement details in hearings
Subscribe or sign in to view the full article.
Article Overview
This article summarizes early regulatory and legislative developments in U.S. health care policy during the start of the Trump administration. It focuses on the Affordable Care Act, a presidential executive order, proposed ACA replacement concepts, and Senate hearing questions surrounding HHS nominee Tom Price. It also touches on Medicare, Medicaid, CMMI, bundled payment initiatives, CHIP, and health IT policy in the context of shifting federal priorities. The piece is aimed at readers following health policy, reimbursement, compliance, and federal agency direction.
Why This Topic Matters
The article helps readers track how federal executive actions, congressional proposals, and confirmation hearings may influence coverage policy, payment models, and administrative enforcement. It is relevant to organizations that need to monitor policy changes affecting reimbursement, benefit design, program oversight, and long-term health system planning.
Article Sections
-
Regulatory update
Overview of recent federal health policy developments under the new administration. Introduces the main areas of ACA-related and regulatory change discussed in the article.
-
President Donald Trump signs executive order on Affordable Care Act (ACA)
Discusses the early executive order related to ACA implementation and the expected scope of its immediate impact. Notes reactions from policy observers and the limits of executive authority.
-
One new GOP ACA replacement allows states to keep Obamacare
Summarizes a newly announced Republican replacement concept and the broad framework described by its sponsors. Covers the general state-option approach and related coverage and financing ideas.
-
Senators demand details on HHS nominee Tom Price’s deals
Covers Senate scrutiny of the HHS secretary nominee’s financial disclosures and related questions raised during the confirmation process. Focuses on the hearings and requests for additional information.
-
Price keeps cool in second hearing
Describes the nominee’s responses during a later hearing and the policy topics raised by senators. Includes discussion of health coverage, Medicare, Medicaid, CHIP, and federal program direction.
-
Expert: Price at HHS means “likely” death for mandatory demos
Presents outside commentary on how the nominee’s leadership could affect mandatory demonstration projects, payment reform, and health IT initiatives. Places these remarks in the context of broader administrative and reimbursement changes.
What You Will Learn
- How early Trump-administration actions were interpreted by health policy observers
- What broad areas of ACA implementation and enforcement were being debated
- Which federal policy topics dominated Tom Price’s confirmation hearings
- How stakeholders were discussing potential changes to Medicare, Medicaid, CHIP, and CMMI priorities
- Why health IT and payment reform programs were part of the broader policy conversation
Who Should Read This
- Health care compliance professionals
- Medical billing and reimbursement staff
- Health policy analysts
- Hospital and physician practice administrators
- Payers and managed care stakeholders
- Federal regulatory watchers
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com